Better Times Ahead For Amicus Therapeutics Inc (NASDAQ: FOLD)?
Amicus Therapeutics Inc (FOLD) concluded trading on Thursday at a closing price of $5.69, with 4.15 million shares of worth about $23.61 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -41.94% during that period and on June 26, 2025 the price saw a […]
Stick With Amicus Therapeutics Inc (FOLD). The Bull Are Alive And Well
Currently, there are 307.92M common shares owned by the public and among those 297.12M shares have been available to trade. The company’s stock has a 5-day price change of -5.07% and -35.41% over the past three months. FOLD shares are trading -38.43% year to date (YTD), with the 12-month market performance down to -45.51% lower. […]
Institutional Exposure To Amicus Therapeutics Inc (FOLD)
Amicus Therapeutics Inc (FOLD) concluded trading on Wednesday at a closing price of $6.14, with 4.8 million shares of worth about $29.47 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -36.90% during that period and on June 11, 2025 the price saw a […]
Growth Story Still Intact For Amicus Therapeutics Inc (FOLD)
Amicus Therapeutics Inc (FOLD) concluded trading on Wednesday at a closing price of $6.10, with 4.52 million shares of worth about $27.59 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -38.88% during that period and on June 04, 2025 the price saw a […]
Assessing Whether Amicus Therapeutics Inc (NASDAQ: FOLD) Is Over- Or Undervalued
Amicus Therapeutics Inc (FOLD) concluded trading on Wednesday at a closing price of $6.10, with 5.5 million shares of worth about $33.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -35.79% during that period and on Wednesday the price saw a loss of […]
Set Your Sights On Amicus Therapeutics Inc (NASDAQ: FOLD)’S Upside Potential
Amicus Therapeutics Inc (FOLD) concluded trading on Thursday at a closing price of $5.95, with 4.21 million shares of worth about $25.07 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -44.34% during that period and on May 15, 2025 the price saw a […]
Do Amicus Therapeutics Inc (NASDAQ: FOLD) Fit In A Value Investing Philosophy?
Currently, there are 307.92M common shares owned by the public and among those 297.53M shares have been available to trade. The company’s stock has a 5-day price change of -17.69% and -36.58% over the past three months. FOLD shares are trading -34.29% year to date (YTD), with the 12-month market performance down to -40.65% lower. […]
Amicus Therapeutics Inc (FOLD): Insights At A Glance
Amicus Therapeutics Inc (FOLD) concluded trading on Wednesday at a closing price of $7.68, with 4.49 million shares of worth about $34.51 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -34.30% during that period and on April 30, 2025 the price saw a […]
Investors Should Take Note Of Amicus Therapeutics Inc (FOLD)
Amicus Therapeutics Inc (FOLD) concluded trading on Wednesday at a closing price of $7.10, with 5.79 million shares of worth about $41.09 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -40.34% during that period and on April 23, 2025 the price saw a […]
Technical Outlook And Game Plan For Amicus Therapeutics Inc (NASDAQ: FOLD)
Amicus Therapeutics Inc (FOLD) concluded trading on Thursday at a closing price of $14.00, with 2.75 million shares of worth about $38.5 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 8.78% during that period and on Thursday the price saw a gain of […]